vs

Side-by-side financial comparison of BayCom Corp (BCML) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $25.9M, roughly 1.3× BayCom Corp). BayCom Corp runs the higher net margin — 26.5% vs -28.1%, a 54.6% gap on every dollar of revenue. On growth, BayCom Corp posted the faster year-over-year revenue change (9.4% vs -18.9%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs 2.9%).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

BCML vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.3× larger
RXST
$32.6M
$25.9M
BCML
Growing faster (revenue YoY)
BCML
BCML
+28.3% gap
BCML
9.4%
-18.9%
RXST
Higher net margin
BCML
BCML
54.6% more per $
BCML
26.5%
-28.1%
RXST
More free cash flow
BCML
BCML
$32.3M more FCF
BCML
$30.1M
$-2.3M
RXST
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
2.9%
BCML

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCML
BCML
RXST
RXST
Revenue
$25.9M
$32.6M
Net Profit
$6.9M
$-9.2M
Gross Margin
77.5%
Operating Margin
36.6%
-34.8%
Net Margin
26.5%
-28.1%
Revenue YoY
9.4%
-18.9%
Net Profit YoY
12.1%
-54.1%
EPS (diluted)
$0.63
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
RXST
RXST
Q4 25
$25.9M
$32.6M
Q3 25
$25.7M
$30.3M
Q2 25
$24.7M
$33.6M
Q1 25
$24.3M
$37.9M
Q4 24
$23.7M
$40.2M
Q3 24
$25.6M
$35.3M
Q2 24
$23.8M
$34.9M
Q1 24
$24.5M
$29.5M
Net Profit
BCML
BCML
RXST
RXST
Q4 25
$6.9M
$-9.2M
Q3 25
$5.0M
$-9.8M
Q2 25
$6.4M
$-11.8M
Q1 25
$5.7M
$-8.2M
Q4 24
$6.1M
$-5.9M
Q3 24
$6.0M
$-6.3M
Q2 24
$5.6M
$-6.1M
Q1 24
$5.9M
$-9.1M
Gross Margin
BCML
BCML
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
BCML
BCML
RXST
RXST
Q4 25
36.6%
-34.8%
Q3 25
26.3%
-40.1%
Q2 25
35.3%
-41.6%
Q1 25
31.6%
-28.2%
Q4 24
34.2%
-21.5%
Q3 24
32.4%
-26.1%
Q2 24
31.9%
-23.9%
Q1 24
33.3%
-36.2%
Net Margin
BCML
BCML
RXST
RXST
Q4 25
26.5%
-28.1%
Q3 25
19.5%
-32.4%
Q2 25
25.8%
-35.0%
Q1 25
23.4%
-21.6%
Q4 24
25.9%
-14.8%
Q3 24
23.5%
-17.9%
Q2 24
23.6%
-17.4%
Q1 24
24.0%
-30.8%
EPS (diluted)
BCML
BCML
RXST
RXST
Q4 25
$0.63
$-0.22
Q3 25
$0.46
$-0.24
Q2 25
$0.58
$-0.29
Q1 25
$0.51
$-0.20
Q4 24
$0.55
$-0.14
Q3 24
$0.54
$-0.16
Q2 24
$0.50
$-0.16
Q1 24
$0.51
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$338.6M
$275.7M
Total Assets
$2.6B
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
RXST
RXST
Q4 25
$228.1M
Q3 25
$227.5M
Q2 25
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
Q3 24
$237.1M
Q2 24
$233.3M
Q1 24
$125.4M
Stockholders' Equity
BCML
BCML
RXST
RXST
Q4 25
$338.6M
$275.7M
Q3 25
$334.3M
$276.0M
Q2 25
$330.6M
$278.0M
Q1 25
$329.3M
$279.3M
Q4 24
$324.4M
$281.2M
Q3 24
$321.7M
$277.3M
Q2 24
$315.3M
$275.2M
Q1 24
$314.2M
$163.9M
Total Assets
BCML
BCML
RXST
RXST
Q4 25
$2.6B
$311.8M
Q3 25
$2.6B
$308.5M
Q2 25
$2.6B
$309.0M
Q1 25
$2.6B
$313.0M
Q4 24
$2.7B
$318.6M
Q3 24
$2.6B
$310.5M
Q2 24
$2.6B
$305.5M
Q1 24
$2.6B
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
RXST
RXST
Operating Cash FlowLast quarter
$31.8M
$-1.1M
Free Cash FlowOCF − Capex
$30.1M
$-2.3M
FCF MarginFCF / Revenue
116.2%
-6.9%
Capex IntensityCapex / Revenue
6.7%
3.5%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$51.1M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
RXST
RXST
Q4 25
$31.8M
$-1.1M
Q3 25
$7.3M
$-1.2M
Q2 25
$6.4M
$-4.4M
Q1 25
$9.3M
$-8.8M
Q4 24
$30.4M
$-4.3M
Q3 24
$9.6M
$650.0K
Q2 24
$7.7M
$-4.0M
Q1 24
$5.1M
$-9.3M
Free Cash Flow
BCML
BCML
RXST
RXST
Q4 25
$30.1M
$-2.3M
Q3 25
$6.2M
$-1.8M
Q2 25
$5.6M
$-5.9M
Q1 25
$9.1M
$-9.4M
Q4 24
$28.7M
$-5.1M
Q3 24
$9.4M
$-453.0K
Q2 24
$7.4M
$-5.5M
Q1 24
$3.9M
$-11.3M
FCF Margin
BCML
BCML
RXST
RXST
Q4 25
116.2%
-6.9%
Q3 25
24.3%
-5.8%
Q2 25
22.8%
-17.6%
Q1 25
37.6%
-24.8%
Q4 24
121.1%
-12.7%
Q3 24
36.6%
-1.3%
Q2 24
31.2%
-15.9%
Q1 24
16.1%
-38.2%
Capex Intensity
BCML
BCML
RXST
RXST
Q4 25
6.7%
3.5%
Q3 25
4.3%
1.9%
Q2 25
3.0%
4.6%
Q1 25
0.6%
1.5%
Q4 24
7.2%
2.1%
Q3 24
1.0%
3.1%
Q2 24
1.0%
4.4%
Q1 24
4.7%
6.7%
Cash Conversion
BCML
BCML
RXST
RXST
Q4 25
4.64×
Q3 25
1.47×
Q2 25
1.00×
Q1 25
1.63×
Q4 24
4.96×
Q3 24
1.60×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BCML
BCML

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons